ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS

QR Code

ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS

Possibilities of modern antiplatelet and antithrombotic therapy at percutaneous coronary interventions in patients with coronary artery disease are surveyed. Data of multicenter randomized clinical trials and meta-analyses are discussed. Possibilities of various drugs at percutaneous coronary interv...

Full description

Saved in:

Bibliographic Details
Main Author:	V. A. Sulimov
Format:	Article
Language:	English
Published:	Столичная издательская компания 2016-01-01
Series:	Рациональная фармакотерапия в кардиологии
Subjects:	percutaneous coronary intervention antithrombotic therapy
Online Access:	https://www.rpcardio.online/jour/article/view/1119
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Thrombosis prevention in percutaneous coronary interventions
by: V. P. Lupanov, et al.
Published: (2009-08-01)

Modern strategy of antithrombotic therapy in patients with coronary artery disease and atrial fibrillation after percutaneous coronary intervention
by: Yu. A. Karpov
Published: (2019-12-01)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019-05-01)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01)

IMMEDIATE RESULTS OF DELAYED PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME
by: S. D. Chevgun, et al.
Published: (2017-12-01)

Modern Antiplatelet Therapy for Percutaneous Coronary Intervention. How to Make the Right Choice?
by: T. M. Uskach, et al.
Published: (2020-12-01)

Antithrombotic Therapy after Bleeding in Elderly Polimorbid Patient: Our Time Challenge
by: M. R. Atabegashvili, et al.
Published: (2018-09-01)

Choice of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention
by: A. N. Golosova, et al.
Published: (2020-08-01)

Up-to-date potential of antithrombotic therapy in patients with coronary artery disease and diabetes
by: O. D. Ostroumova, et al.
Published: (2020-09-01)

Growth differentiation factor 15 and the risk of cardiovascular events in patients with atrial fibrillation after elective percutaneous coronary intervention
by: E. N. Krivosheeva, et al.
Published: (2021-08-01)

Efficiency and safety of various dual antiplatelet therapy strategies in patients undergoing percutaneous coronary intervention due to myocardial infarction
by: S. B. Aksentiev, et al.
Published: (2021-08-01)

BIVALIRUDIN AND PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME: THEORY AND PRACTICE
by: O. V. Averkov
Published: (2012-06-01)

Application of a Nomogram Model in Predicting Postoperative Delirium Following Percutaneous Coronary Intervention
by: Yaxin Xiong, et al.
Published: (2025-06-01)

STATINS AND PERCUTANEOUS CORONARY INTERVENTION. FOCUS ON THE ATORVASTATIN
by: N. G. Gogolashvili
Published: (2015-09-01)

TRANSRADIAL APPROACH DURING PERCUTANEOUS CORONARY INTERVENTIONS. PART 1. EVIDENCE BASE FOR APPLYING A TRANSRADIAL APPROACH
by: Sh. T. Zhamgyrchiev, et al.
Published: (2016-06-01)

HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: O. O. Shakhmatova, et al.
Published: (2016-01-01)

predictors of long-term fatal cardiovascular events after planned percutaneous coronary interventions
by: E. O. Vershinina, et al.
Published: (2018-12-01)

Comorbidities and Percutaneous Coronary Intervention in Elderly Patients with Acute Coronary Syndrome
by: M. Yu. Gilyarov, et al.
Published: (2021-05-01)

ROLE OF GENETIC FACTORS IN THE DEVELOPMENT OF CLOPIDOGREL RESISTANCE AMONG PATIENTS REFERRED FOR PERCUTANEOUS CORONARY INTERVENTIONS
by: S. T. Matskeplishvili, et al.
Published: (2013-08-01)

LONG TERM RESULTS OF PERCUTANEOUS CORONARY INTERVENTIONS COMPARING WITH CONSERVATIVE MANAGEMENT IN TREATMENT OF STABLE ISCHEMIC HEART DISEASE PATIENTS UNDER REAL CIRCUMSTANCES
by: V. A. Kuznetsov, et al.
Published: (2016-02-01)

Recurrent ischemia after percutaneous coronary intervention
by: M. P. Malgina, et al.
Published: (1970-01-01)

Influence of multimorbidity on the risk of events in men with chronic coronary artery disease after myocardial infarction and percutaneous coronary intervention
by: D. V. Dedov, et al.
Published: (2023-12-01)

Prognostic Value of Cardiac Troponin T and Sex in Patients Undergoing Elective Percutaneous Coronary Intervention
by: Yukinori Harada, et al.
Published: (2016-12-01)

Acute Coronary Syndrome after Percutaneous Coronary Intervention: State of the Problem and Clinical Practice Data
by: I. S. Egorova, et al.
Published: (2023-01-01)

Percutaneous coronary interventions for ST elevation myocardial infarction in different age groups
by: I. S. Bessonov, et al.
Published: (2021-04-01)

Distal radial access as an alternative to conventional radial access in coronary angiography and percutaneous coronary interventions
by: A. V. Korotkikh, et al.
Published: (2025-01-01)

Treatment of Patients with Acute Coronary Syndrome with ST Segment Elevation in Clinical Practice of the Republic of Karelia: the Results of 10-year Register
by: I. S. Skopets, et al.
Published: (2020-11-01)

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With 3‐Vessel Coronary Artery Disease and Diabetes
by: Ryaan EL‐Andari, et al.
Published: (2025-06-01)

TRANSRADIAL APPROACH DURING PERCUTANEOUS CORONARY INTERVENTIONS. PART 2. PRACTICAL GUIDELINES AND THE AUTHORS’ DATA
by: A. S. Tereshchenko, et al.
Published: (2016-02-01)

Outcomes of percutaneous coronary intervention in COVID-19-positive acute coronary syndrome patients: a retrospective study in Vietnam
by: Duy Cao Phuong Le, et al.
Published: (2025-07-01)

THE INFLUENCE OF DIABETES MELLITUS ON THE COURSE AND OUTCOMES OF MYOCARDIAL INFARCTION IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS
by: B. U. Mardanov, et al.
Published: (2016-12-01)

Immediate and short-term outcomes of percutaneous coronary intervention in patients with stable and multivessel coronary artery disease, intolerant to coronary artery bypass grafting
by: Sh. Sh. Zaynobidinov, et al.
Published: (2025-05-01)

Antiplatelet medications in acute coronary syndromes and percutaneous coronary interventions: focus on tirofiban
by: T. A. Batyraliev, et al.
Published: (2008-12-01)

Myocardial revascularization by percutaneous coronary intervention in senile patients with chronic total occlusion: a modern view of the problem
by: E. R. Atamanyuk, et al.
Published: (2022-02-01)

Phenotypes of coronary microvascular obstruction phenomenon (no-reflow) during percutaneous coronary interventions in myocardial infarction
by: A. A. Frolov, et al.
Published: (2024-01-01)

New trends in antithrombotic therapy in vascular neurology
by: E. A. Shirokov
Published: (2021-09-01)

Effectiveness, safety, and endothelial function effects of atorvastatin lipid-lowering therapy in coronary heart disease patients undergoing percutaneous coronary intervention
by: M. P. Mal’gina, et al.
Published: (2007-06-01)

HIGH DOSES OF STATINS BEFORE PERCUTANEOUS CORONARY INTERVENTION: WHETHER THERE ARE REASONS TO USE?
by: I. S. Yavelov, et al.
Published: (2017-09-01)

Middle-term results of percutaneous coronary intervention with standard metallic stent “Ephesos II” implantation in patients with coronary heart disease
by: T. A. Batyraliev, et al.
Published: (2011-08-01)

Preparation of patients with type 2 diabetes mellitus for elective percutaneous coronary intervention
by: A. M. Kochergina, et al.
Published: (2023-09-01)